Tina Debeljak
European Medicines Agency’s draft strategy for antimicrobial monitoring
Focus on Regulation ·
EMA’s new guidance on publication of clinical data
Focus on Regulation ·
New draft guidance for Alzheimer’s treatments
Focus on Regulation ·
EUDRAVIGILANCE ACCESS POLICY REVISION
Focus on Regulation ·
CHEMICAL SUBSTANCE CAN QUALIFY AS A “NEW ACTIVE SUBSTANCE”
Focus on Regulation ·